Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Family Practice | 4 | 2020 | 312 | 1.250 |
Why?
|
Down Syndrome | 2 | 2022 | 119 | 1.230 |
Why?
|
Hypothyroidism | 1 | 2020 | 24 | 0.730 |
Why?
|
Thyrotropin | 1 | 2020 | 49 | 0.730 |
Why?
|
Thyroxine | 1 | 2020 | 62 | 0.720 |
Why?
|
Knee | 1 | 2018 | 17 | 0.680 |
Why?
|
Arthralgia | 1 | 2018 | 30 | 0.670 |
Why?
|
Physicians, Family | 2 | 2018 | 82 | 0.660 |
Why?
|
Physical Examination | 1 | 2018 | 152 | 0.630 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 201 | 0.590 |
Why?
|
Alzheimer Disease | 1 | 2022 | 563 | 0.590 |
Why?
|
Education of Intellectually Disabled | 1 | 2014 | 4 | 0.520 |
Why?
|
Dementia | 1 | 2017 | 158 | 0.520 |
Why?
|
Decision Support Systems, Clinical | 2 | 2015 | 88 | 0.510 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 212 | 0.510 |
Why?
|
Radiation Exposure | 1 | 2015 | 84 | 0.480 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 115 | 0.470 |
Why?
|
Cognition Disorders | 1 | 2017 | 342 | 0.470 |
Why?
|
Genetic Testing | 1 | 2014 | 159 | 0.470 |
Why?
|
Practice Patterns, Physicians' | 2 | 2015 | 503 | 0.460 |
Why?
|
Tuberous Sclerosis | 1 | 2012 | 13 | 0.450 |
Why?
|
Guideline Adherence | 1 | 2015 | 284 | 0.440 |
Why?
|
De Quervain Disease | 1 | 2011 | 1 | 0.410 |
Why?
|
Trigger Finger Disorder | 1 | 2011 | 3 | 0.410 |
Why?
|
Thumb | 1 | 2011 | 27 | 0.400 |
Why?
|
Osteoarthritis | 1 | 2011 | 73 | 0.380 |
Why?
|
Tongue Diseases | 1 | 2010 | 14 | 0.370 |
Why?
|
Pain Management | 1 | 2011 | 186 | 0.350 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 2323 | 0.310 |
Why?
|
Clinical Clerkship | 2 | 2018 | 63 | 0.310 |
Why?
|
Pain | 1 | 2011 | 472 | 0.310 |
Why?
|
Quality of Life | 1 | 2014 | 1515 | 0.280 |
Why?
|
Physician's Role | 2 | 2018 | 116 | 0.280 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 1139 | 0.240 |
Why?
|
Humans | 17 | 2023 | 68525 | 0.240 |
Why?
|
alpha-Fetoproteins | 1 | 2023 | 22 | 0.230 |
Why?
|
Patient Care | 1 | 2022 | 61 | 0.200 |
Why?
|
Adult | 6 | 2022 | 21375 | 0.200 |
Why?
|
Electronic Health Records | 2 | 2014 | 374 | 0.190 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 567 | 0.170 |
Why?
|
Feedback | 1 | 2018 | 90 | 0.160 |
Why?
|
Formative Feedback | 1 | 2018 | 8 | 0.160 |
Why?
|
Medical History Taking | 1 | 2018 | 94 | 0.160 |
Why?
|
Rural Health Services | 1 | 2018 | 101 | 0.150 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 1745 | 0.140 |
Why?
|
Hematuria | 1 | 2015 | 24 | 0.130 |
Why?
|
Internet | 1 | 2018 | 390 | 0.130 |
Why?
|
Neonatal Screening | 1 | 2014 | 43 | 0.130 |
Why?
|
Prognosis | 1 | 2020 | 2093 | 0.130 |
Why?
|
Prenatal Diagnosis | 1 | 2014 | 73 | 0.120 |
Why?
|
Severity of Illness Index | 1 | 2020 | 1851 | 0.120 |
Why?
|
Medical Records | 1 | 2014 | 121 | 0.120 |
Why?
|
Double-Blind Method | 2 | 2015 | 1737 | 0.120 |
Why?
|
Clinical Medicine | 1 | 2014 | 20 | 0.120 |
Why?
|
Child | 2 | 2015 | 6400 | 0.120 |
Why?
|
Angiofibroma | 1 | 2012 | 4 | 0.110 |
Why?
|
Warfare | 1 | 2013 | 58 | 0.110 |
Why?
|
Facial Neoplasms | 1 | 2012 | 10 | 0.110 |
Why?
|
Hypopigmentation | 1 | 2012 | 12 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 929 | 0.110 |
Why?
|
Syndrome | 1 | 2012 | 255 | 0.110 |
Why?
|
Antipruritics | 1 | 2011 | 3 | 0.100 |
Why?
|
Intellectual Disability | 1 | 2012 | 114 | 0.100 |
Why?
|
Pruritus | 1 | 2011 | 35 | 0.100 |
Why?
|
Patient Safety | 1 | 2013 | 202 | 0.100 |
Why?
|
Biopsy | 1 | 2012 | 539 | 0.100 |
Why?
|
Female | 4 | 2020 | 38015 | 0.100 |
Why?
|
Glossitis | 1 | 2010 | 2 | 0.090 |
Why?
|
Lichen Planus, Oral | 1 | 2010 | 4 | 0.090 |
Why?
|
Leukoplakia, Hairy | 1 | 2010 | 2 | 0.090 |
Why?
|
Nutrition Disorders | 1 | 2010 | 16 | 0.090 |
Why?
|
Tongue Neoplasms | 1 | 2010 | 28 | 0.090 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 772 | 0.090 |
Why?
|
Atrophy | 1 | 2010 | 112 | 0.090 |
Why?
|
Brain Injuries | 1 | 2013 | 268 | 0.090 |
Why?
|
Decision Making | 1 | 2013 | 410 | 0.090 |
Why?
|
Treatment Outcome | 2 | 2020 | 7028 | 0.090 |
Why?
|
Infant, Newborn | 1 | 2014 | 2453 | 0.080 |
Why?
|
Epilepsy | 1 | 2012 | 336 | 0.080 |
Why?
|
Primary Health Care | 2 | 2014 | 702 | 0.080 |
Why?
|
Mental Disorders | 1 | 2013 | 659 | 0.080 |
Why?
|
Adolescent | 1 | 2018 | 8903 | 0.070 |
Why?
|
Veterans | 1 | 2013 | 904 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2010 | 624 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 2222 | 0.060 |
Why?
|
United States | 4 | 2018 | 7335 | 0.060 |
Why?
|
Cell Phone | 1 | 2018 | 43 | 0.040 |
Why?
|
Societies, Medical | 1 | 2018 | 403 | 0.030 |
Why?
|
Hospitals, Military | 1 | 2014 | 13 | 0.030 |
Why?
|
Clinical Coding | 1 | 2014 | 21 | 0.030 |
Why?
|
Quality Control | 1 | 2014 | 81 | 0.030 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2014 | 69 | 0.030 |
Why?
|
Suicide | 1 | 2013 | 115 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2014 | 7264 | 0.030 |
Why?
|
Histamine Antagonists | 1 | 2011 | 22 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2014 | 1054 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2013 | 782 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2013 | 1241 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2013 | 1506 | 0.010 |
Why?
|
Middle Aged | 1 | 2013 | 21119 | 0.010 |
Why?
|
Male | 1 | 2013 | 37281 | 0.010 |
Why?
|